Holidaymakers have been alerted to a disruption in the supply of a crucial vaccine, which is expected to be 'unavailable' for the next 2-3 weeks. Sanofi has informed NaTHNaC that there will be a ...

Vaccine maker Moderna, Inc. (MRNA) said on Monday that its experimental seasonal flu vaccine demonstrated strong effectiveness in a late-stage study as compared to a currently available standard-dose ...

Travellers have been warned that a key vaccine will be ‘unavailable’ for the next 2-3 weeks. Sanofi has advised NaTHNaC that there will be a disruption in supply of the yellow fever vaccine Stamaril ...

Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved annual flu shot when tested in adults aged 50 years and older in a late-stage ...